Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

BRAF V600E mutation co-existing with oncogenic mutations is associated with aggressive clinicopathologic features and poor prognosis in papillary thyroid carcinoma.

Asian journal of surgery - 1 Jan 2024

Bandoh Nobuyuki, Goto Takashi, Kato Yasutaka, Kubota Akinobu, Sakaue Shota, Takeda Ryuhei, Hayashi Shuto, Hayashi Misaki, Baba Shogo, Yamaguchi-Isochi Tomomi, Nishihara Hiroshi, Kamada Hajime

Abstract excerpt

BACKGROUND: The aim of this study was to evaluate the correlation among mutations in cancer-related genes, clinicopathologic features, and clinical outcome in classical papillary thyroid carcinoma (PTC). PATIENTS AND METHODS: A total of 130 patients with classical PTC who underwent curative surgery between April 2012 and June 2023 at Hokuto Hospital were included. Mutations in targeted regions of 160...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Papillary
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Prognosis

Share to Proto-Oncogene Proteins B-raf

Share to Thyroid Cancer, Papillary

Share to Thyroid Neoplasms

Source

Identifiers

PMID: 37752023
DOI: 10.1016/j.asjsur.2023.09.049

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

BRAF V600E mutation co-existing with oncogenic mutations is associated with aggressive clinicopathologic features and poor prognosis in papillary thyroid carcinoma.PMID 37752023Read ↗

Risk and Prognostic Factors for BRAFV600E Mutations in Papillary Thyroid Carcinoma.Semantic proximity Read ↗

Multi-gene co-mutations of BRAF with TERT, PIK3CA, or TP53 are powerful predictors of central lymph node metastasis in papillary thyroid carcinoma.Semantic proximity Read ↗

A Shift in Molecular Drivers of Papillary Thyroid Carcinoma Following the 2017 World Health Organization Classification: Characterization of 554 Consecutive Tumors With Emphasis on BRAF-Negative Cases.Semantic proximity Read ↗

BRAF V600E Mutation Lacks Association with Poorer Clinical Prognosis in Papillary Thyroid Carcinoma.Semantic proximity Read ↗

Detection of genetic mutations in 855 cases of papillary thyroid carcinoma by next generation sequencing and its clinicopathological features.Semantic proximity Read ↗

The association between BRAF (V600E) mutation and pathological features in PTC.Semantic proximity Read ↗

Distinct molecular subtypes of papillary thyroid carcinoma and gene signature with diagnostic capability.Semantic proximity Read ↗

Papillary Thyroid Carcinoma: Correlation Between Molecular and Clinical Features.Semantic proximity Read ↗

BRAF V600E Co-mutations predict aggressive clinicopathological features in Chinese patients with differentiated thyroid cancer: A multicenter cohort study.Semantic proximity Read ↗

[Correlation between BRAFV600E mutation and aggressive biological behavior of papillary thyroid carcinoma].Semantic proximity Read ↗

BRAF V600E mutation in thyroid carcinoma: a large-scale study in Han Chinese population.Semantic proximity Read ↗

A comparison of the clinicopathological features and prognoses of the classical and the tall cell variant of papillary thyroid cancer: a meta-analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.